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Currently, large EU-funded activities are ongoing to replace animal testing by alternative 
methods. A mini review by Vanhaecke et al. (2009) gives an overview of ongoing EU activi-
ties. The foundations surrounding the assumption of linear dose response relationships for 
carcinogens, together with concepts for thresholds have been intensively discussed during the 
past decade (Bolt et al., 2005; Oesch et al., 2004; Hengstler et al., 2003). A recently published 
review critically assesses the scientific background on how linearity at low dose became ac-
cepted by the scientific community. The table compiles the take home messages from recently 
published articles on regulatory aspects of toxicology. 
 
 
Table 1: Recent publications on regulatory aspects of toxicology 
 
Key message Reference 
 
The minireview gives an overview over the current EU research ac-
tivities in alternative (in vitro) testing. 
Vanhaecke et al., 2009 
A “threshold of sensitization concern” (TSC) concept is described 
which allows classification of chemicals with respect to their ability to 
induce allergic contact dermatitis. 
Keller et al., 2009 
 
The maximum tolerable intake (TDI) for methylmercury was estimated 
to be 0.025 Hg mg/kg/day for monkeys and 0.0046 Hg mg/kg/day for 
humans.  
Yamamoto and Shima, 2009 
A modified protocol of the local lymph node assay can be used to 
study the sensitizing potential of a chemical also following the oral 
route of exposure. 
Ahuja et al., 2009 
 
This review critically assesses the foundations of how linearity at low 
dose became accepted by the scientific community. Although its 
foundations have been challenged, there has been little practical 
change in regulatory policy. 
Calabrese, 2009a (review) 
Bolt et al., 2009 (editorial) 
Pesch et al., 2009 (editorial) 
This minireview summarizes the state of the art as well as perspec-
tives in using induced pluripotent stem cells for toxicology screening. 
Heng et al., 2009 
This review challenges the threshold model of dose-response rela-
tionships and presents evidence that the hormesis model has per-
formed better in the low dose range. 
Calabrese, 2009b 
A user-friendly, freely available software for the statistical evaluation 
of the in vivo micronucleus test is presented. 
Hothorn and Gerhard, 2009 
This editorial gives a short summary of the discussion on the role of 
alternative methods in the context of REACH. 
Gundert-Remy et al., 2009 
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